Skip to content
ppharmaranks
Menu

ENSPRYNG vs UPLIZNA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 10, 2026·How we rate

Possible drug interaction. ENSPRYNG and UPLIZNA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

72/100
New

Pharmacy pays

—
—

Type

RX
RX

Active ingredient

SATRALIZUMAB
INEBILIZUMAB-CDON

Dosage forms

Injectable
Injectable

Drug class

—
—

Boxed warning

None
None

Treats

Neuromyelitis Optica
Neuromyelitis Optica

Frequently asked questions

What is the difference between Enspryng and Uplizna?

Enspryng contains Satralizumab, while Uplizna contains Inebilizumab-Cdon — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.